Skip to main content
Clinical Trials/NCT00549952
NCT00549952
Unknown
Not Applicable

Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients

Korea Otsuka Pharmaceutical Co., Ltd.1 site in 1 countryOctober 2007
ConditionsOral Mucositis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oral Mucositis
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Locations
1
Primary Endpoint
incidence and severity of oral mucositis
Last Updated
18 years ago

Overview

Brief Summary

to survey oral mucositis after chemotherapy and Concurrent chemoradiotherapy in Korean cancer patients

Registry
clinicaltrials.gov
Start Date
October 2007
End Date
March 2008
Last Updated
18 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with one cancer among head and neck cancer, esophageal cancer, breast cancer, colorectal cancer, gastric cancer, and non-small cell lung cancer, who are being treated or going to be treated as one between A and B A. Chemotherapy only B. Concurrent chemoradiotherapy

Exclusion Criteria

  • Patients who are pregnant or breast feeding, absent from effective(medically proven) contraceptive method for females of childbearing potential
  • Patients with performance status of ECOG score is more than 3

Outcomes

Primary Outcomes

incidence and severity of oral mucositis

Study Sites (1)

Loading locations...

Similar Trials